PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
136 hedge funds and large institutions have $279M invested in PDL BioPharma, Inc. in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
Holders
136
Holding in Top 10
2
Calls
$245K
Puts
$75K
Top Buyers
| 1 | +$8.2M | |
| 2 | +$3.57M | |
| 3 | +$2.21M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.19M |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
+$2.04M |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$2.01M | |
| 3 | -$1.76M | |
| 4 |
ECM
Engine Capital Management
New York
|
-$1.41M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.24M |